The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 28, 2020
Filed:
Dec. 27, 2013
Chong Kun Dang Pharmaceutical Corp., Seoul, KR;
Sang Phil Yoon, Gyeonggi-do, KR;
Ki Seong Ko, Gyeonggi-do, KR;
Ha Na Yu, Gyeonggi-do, KR;
Hye Jung Baik, Gyeonggi-do, KR;
Won Kyu Yang, Gyeonggi-do, KR;
Jin Young Ko, Gyeonggi-do, KR;
So Hyun Park, Gyeonggi-do, KR;
Sung Bum Jung, Gyeonggi-do, KR;
Sung Won An, Gyeonggi-do, KR;
Min Hyo Ki, Gyeonggi-do, KR;
Chong Kun Dang Pharmaceutical Corp., Seoul, KR;
Abstract
Disclosed is a pharmaceutical composition, comprising: a) at least one sorbitan unsaturated fatty acid ester having a polar head with at least two or more —OH (hydroxyl) groups; b) at least one phospholipid; c) at least one liquid crystal hardener which is free of an ionizable group and has a triacyl group with 15 to 40 carbon atoms or a carbon ring structure in a hydrophobic moiety; and d) at least one GnRH (gonadotropin-releasing hormone) analogue as a pharmacologically active substance, wherein said lipid pre-concentrate exists as a liquid phase in absence of aqueous fluid and forms into a liquid crystal in presence of aqueous fluid. The pharmaceutical composition is configured to enhance the sustained release of the pharmacologically active substance GnRH analogue.